Immune checkpoint inhibitor induced large vessel vasculitis. Issue 5 (18th May 2020)

• Record Type: Journal Article
• Authors: Henderson, Daisy; Eslamian, Gelareh; Poon, Daniel; Crabb, Simon; Jones, Robert; Sankey, Peter; Kularatne, Bihani; Linch, Mark; Josephs, Debra
• Is Part Of: BMJ case reports. Volume 13:Issue 5(2020)
• Publication Date: 2020-05-18
• Subjects: prostate cancer -- vasculitis -- unwanted effects / adverse reactions -- immunology -- cancer intervention; Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2019-233496
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : This is a case report of a 67-year-old patient with castration resistant metastatic prostate cancer who developed an immune-mediated large vessel vasculitis following treatment with ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1).